Jong Yeon Hwang

1.4k total citations
68 papers, 1.1k citations indexed

About

Jong Yeon Hwang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jong Yeon Hwang has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 23 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Jong Yeon Hwang's work include Protein Degradation and Inhibitors (10 papers), Cancer therapeutics and mechanisms (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Jong Yeon Hwang is often cited by papers focused on Protein Degradation and Inhibitors (10 papers), Cancer therapeutics and mechanisms (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Jong Yeon Hwang collaborates with scholars based in South Korea, United States and India. Jong Yeon Hwang's co-authors include Young‐Dae Gong, Chi Hoon Park, Jae Du Ha, Chong Ock Lee, Chung Hyo Kang, Duck‐Hyung Lee, R. Kiplin Guy, Fangyi Zhu, Michele Connelly and Sung‐Eun Yoo and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Jong Yeon Hwang

66 papers receiving 1.1k citations

Peers

Jong Yeon Hwang
Comparison fields: 5 of 99
  • Molecular Biology 577
  • Organic Chemistry 426
  • Oncology 207
  • Hematology 101
  • Pulmonary and Respiratory Medicine 83
Suhui Yang South Korea
Pan Tang China
Alexander V. Kachur United States
Kelly Duncan United States
Wenhua Jiang China
Charles J. R. Hedgecock United Kingdom
Ruchi Saxena India
Mohammad Askandar Iqbal India
Alan Knapton United States
Suhui Yang South Korea View profile →
Citations per field, relative to Jong Yeon Hwang
Jong Yeon Hwang · 1×
Citations per year, relative to Jong Yeon Hwang
Jong Yeon Hwang · 1×

Countries citing papers authored by Jong Yeon Hwang

Since Specialization
Citations

This map shows the geographic impact of Jong Yeon Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Yeon Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Yeon Hwang more than expected).

Fields of papers citing papers by Jong Yeon Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Yeon Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Yeon Hwang. The network helps show where Jong Yeon Hwang may publish in the future.

Co-authorship network of co-authors of Jong Yeon Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Yeon Hwang. A scholar is included among the top collaborators of Jong Yeon Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Yeon Hwang. Jong Yeon Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers Bioorganic & Medicinal Chemistry Letters Seulki Park, Jaehoon Kim et al. 2
2 Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle Bioorganic & Medicinal Chemistry Letters Nengwei Yu, Ji‐Eun Lee et al. 1
3 Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model Bioorganic Chemistry Seulgi Kim, Yuri Choi et al. 17
4 Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC) Biochemical and Biophysical Research Communications Chung Hyo Kang, Chong Ock Lee et al. 103
5 Applications of Hydrochemical Models for the Assessment of Groundwater Jong Yeon Hwang, Sunhwa Park et al. 5
6 Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Molecules Joo‐Youn Lee, Ji‐Eun Jeong et al. 7
7 Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor Bioorganic & Medicinal Chemistry Letters Chong Ock Lee, Hyoung Rae Kim et al. 11
8 Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors Archives of Pharmacal Research Eun Young Kim, Heejung Jung et al. 11
9 Mutual collision of water jets from adjacent high pressure flat jet nozzles on flat surfaces during hydraulic descaling Tehnicki vjesnik - Technical Gazette Miroslav Raudenský, Jong Yeon Hwang et al. 1
10 Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions Antiviral Research Sangmi Oh, Jaewon Yang et al. 9
11 Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R European Journal of Medicinal Chemistry Chung Hyo Kang, Heung Kyoung Lee et al. 14
12 Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer Cancer Letters Chung Hyo Kang, Eun Young Kim et al. 12
13 Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins Biochemical and Biophysical Research Communications Chung Hyo Kang, Kwangho Lee et al. 4
14 Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors Bioorganic & Medicinal Chemistry Chi-Min Park, Joo Yun Lee et al. 11
15 Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors Bioorganic & Medicinal Chemistry Letters Eun‐Young Kim, Heejung Jung et al. 11
16 Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action European Journal of Medicinal Chemistry Marc P. Windisch, Soohyun Kim et al. 14
17 Optimization of the electrophile of chloronitrobenzamide leads active against Trypanosoma brucei Bioorganic & Medicinal Chemistry Letters Jong Yeon Hwang, David C. Smithson et al. 11
18 Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone Journal of Biological Chemistry Jong Yeon Hwang, Wenwei Huang et al. 31
19 Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis Bioorganic & Medicinal Chemistry Letters Jong Yeon Hwang, David C. Smithson et al. 8
20 Index of Organic Matter in Stream and Lake Journal of Environmental Impact Assessment Soonju Yu, Jong Yeon Hwang et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026